A detailed history of Israel Englander (Millennium Management LLC) transactions in Insmed Inc stock. As of the latest transaction made, Millennium Management LLC holds 1,198,510 shares of INSM stock, worth $87.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,198,510
Previous 276,618 333.27%
Holding current value
$87.3 Million
Previous $7.5 Million 970.1%
% of portfolio
0.04%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $20.3 Million - $64.3 Million
921,892 Added 333.27%
1,198,510 $80.3 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $34.2 Million - $39.8 Million
-1,328,383 Reduced 82.77%
276,618 $7.5 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $35.5 Million - $48.1 Million
1,514,139 Added 1666.42%
1,605,001 $49.7 Million
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $2.58 Million - $3.32 Million
-157,129 Reduced 63.36%
90,862 $1.92 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $4.03 Million - $5.39 Million
247,991 New
247,991 $4.23 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $14.2 Million - $19.2 Million
680,999 Added 284.84%
920,077 $19.8 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $3.18 Million - $4.79 Million
186,407 Added 353.91%
239,078 $4.72 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $211,142 - $290,864
10,340 Added 24.43%
52,671 $1.24 Million
Q4 2021

Feb 14, 2022

BUY
$25.89 - $33.45 $1.1 Million - $1.42 Million
42,331 New
42,331 $1.15 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $263,972 - $346,360
-11,753 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $109,586 - $163,269
4,534 Added 62.81%
11,753 $334,000
Q1 2021

May 17, 2021

SELL
$32.28 - $44.3 $1.59 Million - $2.19 Million
-49,372 Reduced 87.24%
7,219 $246,000
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $4.3 Million - $5.54 Million
-136,622 Reduced 70.71%
56,591 $1.88 Million
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $2.86 Million - $3.79 Million
-109,965 Reduced 36.27%
193,213 $6.21 Million
Q2 2020

Aug 14, 2020

SELL
$14.11 - $29.42 $1.79 Million - $3.74 Million
-127,113 Reduced 29.54%
303,178 $8.35 Million
Q1 2020

May 14, 2020

SELL
$13.63 - $33.98 $5.38 Million - $13.4 Million
-394,419 Reduced 47.83%
430,291 $6.9 Million
Q4 2019

Feb 14, 2020

BUY
$16.12 - $24.98 $7.94 Million - $12.3 Million
492,442 Added 148.21%
824,710 $19.7 Million
Q1 2019

May 14, 2019

BUY
$13.91 - $31.15 $4.47 Million - $10 Million
321,153 Added 2889.37%
332,268 $9.66 Million
Q4 2018

Feb 14, 2019

BUY
$11.6 - $18.7 $128,934 - $207,850
11,115 New
11,115 $146,000
Q3 2018

Nov 14, 2018

SELL
$18.95 - $28.08 $220,559 - $326,823
-11,639 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $232,780 - $345,911
11,639 New
11,639 $275,000
Q1 2018

May 15, 2018

SELL
$21.69 - $32.99 $507,307 - $771,603
-23,389 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $3.87 Million - $4.65 Million
-146,432 Reduced 86.23%
23,389 $729,000
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $1.97 Million - $5.3 Million
169,821
169,821 $5.3 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.87B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.